Two cases of somatic STK11 mosaicism in Danish patients with Peutz-Jeghers syndrome.


Journal

Familial cancer
ISSN: 1573-7292
Titre abrégé: Fam Cancer
Pays: Netherlands
ID NLM: 100898211

Informations de publication

Date de publication:
01 2021
Historique:
received: 24 04 2020
accepted: 28 05 2020
pubmed: 7 6 2020
medline: 30 11 2021
entrez: 7 6 2020
Statut: ppublish

Résumé

Peutz-Jeghers syndrome (PJS) is a hereditary polyposis syndrome characterized by hamartomatous Peutz-Jeghers polyps in the gastrointestinal tract, mucocutaneous pigmentations, and increased risk for intestinal and extraintestinal cancer. In more than two-third of patients it is possible to detect pathogenic variants in the serine/threonine kinase 11 (STK11) gene, but so far is knowledge about genetic causes in the remaining part of patients limited. Reports of STK11 mosaicism are rare but may be an explanation in some patients without initial findings of pathogenic variants in STK11. We report two Danish patients with STK11 mosaicism detected in blood when using Next-Generation Sequencing. This is only the sixth and seventh patient reported in the literature, and we compare phenotypes of the reported cases. The results indicate that STK11 mosaicism is more frequent than anticipated and highlight that mosaicism should be considered in patients with clinical suspicion of PJS or patients fulfilling the diagnostic criteria.

Identifiants

pubmed: 32504210
doi: 10.1007/s10689-020-00191-4
pii: 10.1007/s10689-020-00191-4
doi:

Substances chimiques

Protein Serine-Threonine Kinases EC 2.7.11.1
STK11 protein, human EC 2.7.11.1
AMP-Activated Protein Kinase Kinases EC 2.7.11.3

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

55-59

Références

WHO International Classification of Diseases (ICD-10). vol. 2016 Jun 15
Jelsig AM, Qvist N, Sunde L et al (2016) Disease pattern in Danish patients with Peutz-Jeghers syndrome. Int J Colorectal Dis 31:997–1004. https://doi.org/10.1007/s00384-016-2560-3
doi: 10.1007/s00384-016-2560-3 pubmed: 26979979
Utsunomiya J, Gocho H, Miyanaga T, Hamaguchi E, Kashimure A (1975) Peutz-Jeghers syndrome: its natural course and management. Johns Hopkins Med J 136(2):71–82
pubmed: 1117595
Hearle N, Schumacher V, Menko FH et al (2006) Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12(10):3209–3215. https://doi.org/10.1158/1078-0432.ccr-06-0083
doi: 10.1158/1078-0432.ccr-06-0083 pubmed: 16707622
Beggs AD, Latchford AR, Vasen HF et al (2010) Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut 59(7):975–986. https://doi.org/10.1136/gut.2009.198499
doi: 10.1136/gut.2009.198499
McKay V, Cairns D, Gokhale D, Mountford R, Greenhalgh L (2016) First report of somatic mosaicism for mutations in STK11 in four patients with Peutz-Jeghers syndrome. Fam Cancer 15(1):57–61. https://doi.org/10.1007/s10689-015-9839-3
doi: 10.1007/s10689-015-9839-3 pubmed: 26386697
Butel-Simoes GI, Spigelman AD, Scott RJ, Vilain RE (2019) Low-level parental mosaicism in an apparent de novo case of Peutz-Jeghers syndrome. Fam Cancer 18(1):109–112. https://doi.org/10.1007/s10689-018-0093-3
doi: 10.1007/s10689-018-0093-3 pubmed: 29948449
Boudeau J, Kieloch A, Alessi DR, Stella A, Guanti G, Resta N (2003) Functional analysis of LKB1/STK11 mutants and two aberrant isoforms found in Peutz-Jeghers Syndrome patients. Hum Mutat 21(2):172. https://doi.org/10.1002/humu.9112
doi: 10.1002/humu.9112 pubmed: 12552571
Fernandez-Marmiesse A, Gouveia S, Couce ML (2018) NGS technologies as a turning point in rare disease research, diagnosis and treatment. Curr Med Chem 25(3):404–432. https://doi.org/10.2174/0929867324666170718101946
doi: 10.2174/0929867324666170718101946 pubmed: 28721829 pmcid: 5815091
Kim B, Won D, Jang M et al (2019) Next-generation sequencing with comprehensive bioinformatics analysis facilitates somatic mosaic APC gene mutation detection in patients with familial adenomatous polyposis. BMC Med Genomics 12(1):103. https://doi.org/10.1186/s12920-019-0553-0
doi: 10.1186/s12920-019-0553-0 pubmed: 31269945 pmcid: 6610853

Auteurs

Anne Marie Jelsig (AM)

Deparment of Clinical Genetics, University Hospital of Copenhagen, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. anne.marie.jelsig@regionh.dk.

Birgitte Bertelsen (B)

Center for Genomic Medicine, University Hospital of Copenhagen, Rigshospitalet, Denmark.

Isabel Forss (I)

Center for Genomic Medicine, University Hospital of Copenhagen, Rigshospitalet, Denmark.

John Gásdal Karstensen (JG)

Danish Polyposis Registry, Hvidovre Hospital, Gastrounit, Hvidovre, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH